Microparticles comprising GNRH made by PGSS
US10441626B2 · kind B2 · utility
1Cited by
2References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2014 |
| Grant date | Oct 15, 2019 |
| Priority date | — |
| Expiry date | Oct 7, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical formulation comprising a solid matrix of one or more biodegradable polymers, the solid matrix including a pharmaceutically active substance or a pharmaceutically acceptable salt thereof distributed homogeneously or substantially homogeneously within the matrix; wherein the pharmaceutically active substance is, for example, a gonadotropin releasing hormone (GnRH), a GnRH agonist or a GnRH antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.